U.S. stock futures were poised for a lower open on Tuesday as traders, who just returned from the long Labor Day weekend, reacted to North Korea's most powerful nuclear test over the weekend.
Oil prices nudged higher with global benchmark Brent Crude up 0.44% recently, and U.S. benchmark West Texas Intermediate up 1.33% as refineries in the Gulf of Mexico powered back up after the disruptions caused by Hurricane Harvey.
At 10 a.m., data are expected to show factory orders falling 3.1% in July vs a prior gain of 3%, according to data compiled by Econoday.
In equities, shares of Insmed ( INSM ) more than doubled in value pre-bell after the company reported results from its phase 3 Convert study of Amikacin Liposome Inhalation Suspension in adult patients with treatment-refractory non-tuberculous mycobacterial lung disease which met its primary endpoint.
U.S. PRE-MARKET INDICATORS
-Dow Jones Industrial down 0.31%
-S&P 500 futures down 0.21%
-Nasdaq 100 futures down 0.21%
-Nasdaq 100 pre-market indicator down 0.17%
Nikkei down 0.63%
Hang Seng flat 0%
Shanghai Composite up 0.14%
FTSE-100 down 0.09%
DAX-30 up 0.47%
PRE-MARKET SECTOR WATCH
(+/-) Large cap tech: mixed
(+/-) Chip stocks: mixed
(+/-) Software stocks: mixed
(-) Hardware stocks: unchanged to lower
(-) Internet stocks: lower
(+) Oil stocks: unchanged to higher
(+/-) Biotech stocks: mixed
(+/-) Drug stocks: mixed
(-) Financial stocks: unchanged to lower
(+/-) Retail stocks: mixed
(+/-) Industrial stocks: mixed
(-) Airlines: unchanged to lower
(+/-) Autos: mixed
(+) COL (+1.4%) Agrees to $30 billion buyout by United Technologies
(+) BCRX (+12.6%) Reports positive results from APeX-1 phase 2 trial in HAE
(+) NVCN (+5.3%) Co.'s reducer system reviewed in European Heart Journal
(-) CLLS (-31%) FDA places clinical hold on UCART123 studies following fatality
(-) FCAU (-0.7%) CEO says no 'big deal' on horizon
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.